[The intestinal microbiota and obesity of the host].
The growing population of overweight humans threatens both industrialized and developing countries and has been accompanied by obesity-related disorders, including type II diabetes, hypertension, cardiovascular pathology and nonalcoholic fatty liver disease. Recent researches have demonstrated that intestinal microbiota may be associated with the host's obesity. There were researches on the interaction between Bacteroides thetaiotaomicron and the energy metabolism of the host. Methanobrevibacer smithii had been improved to impact the host's energy metabolism through modulating the gene transcription of B. thetaiotaomicron. The microbiota can direct the host to increase hepatic production of triglycerides, promote storage of triglycerides in adipocytes through suppression of intestinal expression of a circulating LPL inhibitor, and have an effect on the host's energy deposition through the interaction with host's hormones (eg. Leptin) . Some metabolic products of the microbiota like SCFAs, other organic acids, alcohols and gases can be used by the host directly. Researches mentioned above are just started. According to the results above, some key points remain unknown. For example, the underlying mechanism of the interaction between microbiota or some unique microbes and the host, the procedure of dietary polysaccharides degradation of the microbes, and the relationship between the microbiota and the host's hormones. In this paper, the corresponding research results of author' s lab has also been reviewed and the future research prospect s have been summarized.
Luo
Yu-Heng
YH
(Lab of animal gastrointestinal microbiology, college of animal science and technology, Nanjing Agricultural University, Nanjing 210095, China). luoluo212@126.com
Zhu
Wei-Yun
WY
D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins / Q000502:physiology; D000818:Animals; D001419:Bacteria / Q000378:metabolism*; D004734:Energy Metabolism; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D020738:Leptin / Q000502:physiology; D008697:Methane / Q000378:metabolism; D009765:Obesity / Q000209:etiology*; D014280:Triglycerides / Q000378:metabolism
C474772:ANGPTL4 protein, human; D000075803:Angiopoietin-Like Protein 4; D042682:Angiopoietins; D020738:Leptin; D014280:Triglycerides; D008697:Methane